James Hoyes is the President of EMD Serono, Inc. In this capacity, his responsibilities include driving the strategic direction of the US organization as well as managing the day-to-day operations of the US subsidiary of Merck KGaA, Darmstadt, Germany. As head of the US business, Mr. Hoyes is a member of several global management teams. In his previous role as Chief Commercial Officer, he was responsible for business operations in the company's key therapeutic areas of neurodegenerative disease, rheumatology, fertility and metabolic endocrinology, as well as Managed Care, Business Intelligence, Health Outcomes, Specialty Pharmacy and Commercial Operations.
One of the "Most Inspiring People"
In the July/August 2010 Special Edition of PharmaVOICE, James Hoyes was featured among the 100 Most Inspiring People in the Pharmaceutical Industry. His leadership style, the article says, "is fashioned strongly by collaboration and transparency".
In his previous role as Executive Vice President, he managed the operations of sales, marketing, communications, call center operations, and medical affairs for the Neurology portfolio. He joined EMD Serono in February 2004 as Vice President of Marketing in Neurology. Prior to EMD Serono, Mr. Hoyes gained experience in a variety of commercial roles of increasing responsibilities at Elan, Sanofi-Synthelabo, Sanofi and Sterling Drug. Mr. Hoyes also has extensive experience working in a partnership environment (such as co-promotion and joint venture agreements) with other biopharmaceutical companies such as Pfizer, BMS, UCB and Wyeth.
Mr. Hoyes graduated from Pennsylvania State University with a Bachelor of Science in Biology.